Definitive Contract W91YTV13C0006

This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of radiopharmaceutical products. The contract has a ceiling value of $51,390.92 and a period of performance through December 31, 2024. The award is for the provision of critical radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT), which are used in...

This is a $488,270.50 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Southeast Apothecary Opelika, Inc., a woman-owned small disadvantaged business, for the delivery of unit dose radiopharmaceuticals to Martin Army Community Hospital at Fort Benning, Georgia. The contract has an ultimate completion date of September 30, 2025. This award was not set aside for any specific small business program. The original pre-solicitation notice, posted on October 2, 2020,...

This is a federal contract award issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer of radiopharmaceuticals. The $108,500 firm-fixed-price delivery order is for the radiopharmaceutical drug DOTATATE, which is used in nuclear medicine procedures. The contract is not set aside and is awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle....

This is a federal contract awarded by the Defense Health Agency (DHA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract, valued at $258,331.00, is for the delivery of MERTIATIDE MAG3, COMPOUNDED R057A0 I-131 CAPSULES, a radiopharmaceutical product used for diagnostic imaging and treatment procedures. The contract is a firm-fixed-price purchase order without any set-aside designation. Jubilant Radiopharma is a for-profit, self-certified small...

This is a federal delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer...

This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract, worth up to $80,000.00, is for the delivery of various radiopharmaceuticals to military treatment facilities to support nuclear medicine diagnostic services for active duty...

The Department of Veterans Affairs Veterans Health Administration awarded a delivery order to Cardinal Health 414, LLC for the supply of unit dose radiopharmaceuticals for nuclear medicine at the Fort Wayne, IN VA Medical Center. The firm fixed price contract, which does not have a set-aside designation, was exercised for option year 1 and has a potential value of $105,596.32. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc., which has...

Advanced Accelerator Applications USA Inc. was awarded a $227,236 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) by the Defense Health Agency. The delivery order is for seven units of PLUVICTOR (lutetium-177), a radiopharmaceutical drug, to be delivered to a location in New York by September 30, 2023. No set-aside provisions were applied to this award, which was issued on October 17, 2022 to support the Defense Health Agency's...

<p>Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a firm fixed-price contract by the Defense Health Agency to deliver radiotherapeutic pharmaceutical RADDIUM RA223 DICHLORIDE. The $12,714.06 contract was issued through the Basic Purchasing Agreement call and has a completion date of September 30, 2021. Performance will take place in Dublin, Ohio. No set-aside designation was applied to this procurement for the requested radiotherapeutic product.</p>

This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, which are radioactive pharmaceuticals used in nuclear medicine, oncology, and diagnostic imaging. The contract has a ceiling value of $229,022.00 and is a firm fixed price contract. The contract is not a set-aside. Cardinal Health 414 has been awarded multiple Indefinite...